ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

• Frank Maldarelli ,

  *To whom correspondence should be addressed. E-mail: fmalli@mail.nih.gov

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Sarah Palmer,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Martin S King,

  Affiliation Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois, United States of America

  ⨯
• Ann Wiegand,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Michael A Polis,

  Affiliation Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• JoAnn Mican,

  Affiliation Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Joseph A Kovacs,

  Affiliation Department of Critical Care, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Richard T Davey,

  Affiliation Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Diane Rock-Kress,

  Affiliation Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Robin Dewar,

  Affiliation SAIC-Frederick, Frederick, Maryland, United States of America

  ⨯
• Shuying Liu,

  Affiliation Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Julia A Metcalf,

  Affiliation Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Catherine Rehm,

  Affiliation Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Scott C Brun,

  Affiliation Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois, United States of America

  ⨯
• George J Hanna,

  Affiliation Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois, United States of America

  ⨯
• Dale J Kempf,

  Affiliation Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois, United States of America

  ⨯
• John M Coffin,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
•  [ ... ],
• John W Mellors

  Affiliation Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America

  ⨯
• [ view all ]
• [ view less ]